Market Research Blog – Page 13320 – New Product Development

DNA/RNA Extraction Market Estimated to Expand at a Robust CAGR By 2029

DNA/RNA Extraction Market Overview

DNA/RNA Extraction: Market Insights

In recent past, there has been advancement in automation technologies, resulting in more accurate and effective analysis. Global key players have developed many new and broad range of DNA/RNA extraction kits which are fast, accurate and easy to use for analysis of microorganisms, animal, food and environmental samples. DNA/RNA extraction kits have been optimized in combination with PCR and electrophoresis equipments for rapid identification and quantification of DNA/RNA samples. The isolated DNA/RNA can be used directly in PCR assays using tailor made kits that efficiently work with all type of sample matrices. DNA/RNA extraction techniques are performed in hospital laboratories, diagnostic laboratories, academic & research laboratories, biopharmaceutical companies, forensic laboratories and contract research organization.

DNA/RNA Extraction Market: Drivers and Restraints

DNA/RNA extraction market is anticipated to grow significantly over the forecast period. The growth of the market will be largely influenced by decrease in cost of genetic engineering products, strong growth and development in personalized medicine and other diagnostic tools. Growing research in isolation, extraction and purification of nucleic acid will lead to the growth of DNA/RNA extraction market globally

Some of the major players operating in DNA/RNA extraction market include Danaher, Qiagen, Roche, Illumina, Thermo Fischer Scientific and Agilent Technologies. Over the years, these companies with huge investments in product development are evolving at a faster rate in DNA/RNA extraction market The key revenue based growth to these players haven due to product related agreements and tie-ups with medical devices and healthcare care companies around the world.

Many small and emerging players are also interested in strategic partnerships and agreements with global firms to expand their both genomic and proteomic business across all geographies For instance, in July 2019, RevoluGen, a UK based small molecular chemistry and research company announced global distribution collaboration with Merck for its unified high molecular weight DNA extraction and size selection product Fire Monkey / Fire Flower.

DNA/RNA Extraction Market: Overview

DNA/RNA extraction is a combinational process for nucleic acid extraction by means of quantitative analysis using extractions kits and sophisticated instruments. The genomic method helps in eliminating the need for mechanical disruption and labor. Additionally, enhanced protocols and a new DNA/RNA extraction kits available in the market helps in delivering reproducible high quality DNA/RNA extraction results. It is anticipated that rise in R&D funding, increased preference for automation and advancement in technology will majorly drive the market for DNA/RNA extraction. Besides, increase demand for user-friendly products is also expected to drive the market for DNA/RNA extraction However, lack of new product awareness and low levels of product penetration in undeveloped nations will impede the growth of DNA/RNA extraction market in the forecast period.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-10543

DNA/RNA Extraction Market: Regional Outlook

Globally, North America is anticipated to be the leading regional market for DNA/RNA extraction. Growing genomic and proteomic research along with research collaborations amongst research institutes and hospital laboratories for clinical DNA/RNA data analysis are some of the major developments that will fuel the growth of DNA/RNA extraction market. The regional North America market for DNA/RNA extraction is also going to be driven by the presence manufacturing hubs of key companies operating in DNA/RNA extraction market. Europe, East and South Asian DNA/RNA extraction market will also show a tremendous growth potential in the forecast period. Increasing awareness and preference of new and innovative technologies across these three region is going to drive the market of DNA/RNA Extraction in the future followed by Oceania and Middle East & Africa.

DNA/RNA Extraction Market: Key Players

Some of the key players operating in the global DNA/RNA extraction market are Thermo Fisher Scientific Inc, Primerdesign, QIAGEN N.V., RevoluGen, Bioneer corp, MO BIO Laboratories, BioFire Defense, General Biosystems, Akonni Biosystems, Promega Corporation, Bio-Rad Laboratories, and many more.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, Peru, Chile, Rest of LATAM)
Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
CIS & Russia
Japan
Asia Pacific Excluding Japan ( Greater China, India, South Korea, ASEAN Countries, Rest of APEJ)
Middle East and Africa (GCC Countries, Turkey, Iran, Israel, S. Africa, Rest of MEA)

For any queries linked with the report, ask an analyst >> https://www.futuremarketinsights.com/ask-question/rep-gb-10543

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The plastic tube market totals US $ 959 million. Demand for flexible and see-through packaging to promote sales in the cosmetics industry

According to Future Market Insights (FMI), the plastic tube market will gain traction by expanding the cosmetics and pharmaceutical industries. Plastic tube sales are expected to grow at a CAGR of 5.0% between 2021 and 2031 .

Plastic tubes are expected to record a surge in demand due to the rapid expansion of the cosmetics industry around the world. Future Market Insights predicts that the global plastic tubing market will be driven by increased attention to enhanced product design and customization of packaging structures.

Plastic tubes are mainly used in the cosmetics, pharmaceutical and food industries to package and store viscous or pasty substances. Plastic tubes have been extremely popular with end users for many years due to their outstanding dispensing properties and convenient packaging structure.

Request a sample to “go ahead” of your competitors @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4757

In addition, by incorporating improved barrier properties into plastic tubing, its range of application has been greatly expanded.

Plastic tubing provides end users with accurate packaging and attracts millennials for its aesthetic packaging and smooth texture. By incorporating advanced printing technologies such as flexographic printing and offset printing into plastic tubes, we are increasing brand value and increasing sales.

Printing on flexible plastic tubes is an effective technique to help brand owners differentiate their products from competing products already available on the market. Large and small manufacturers operating in the global plastic tube market are using these printing technologies to make more attractive plastic tubes.

Therefore, the growing preference for these attractive printed plastic tubes may drive the sale of plastic tubes during the forecast period. According to the survey, the global plastic tube market is expected to exceed US $ 959 million by the end of 2031 .

Important point

Based on the material, the polyethylene (PE) segment is expected to record a CAGR of approximately 5% between 2021 and 2031 due to its low cost and additional protection for internal materials .
In terms of capacity, the 101-150 ml plastic tubing segment is expected to increase its current market share by 170 bps over the next decade .
Stand-up caps are the most preferred closure type in the plastic tubing market, creating an incremental opportunity of US $ 306 million during the forecast period .
In terms of applications, the cosmetics segment is expected to hold nearly 52.2 % of the market share by 2021 .
Regionally, Eastern and Western Europe combined are expected to contribute more than 37.6% in 2021 .

Request TOC @ for more information on the research approach used in the report . https://www.futuremarketinsights.com/toc/rep-gb-4757

“ With the introduction of innovative printing and the launch of enhanced product design with the availability of stand-up caps and nozzle caps, plastic tube sales are increasing, but we do business in the global plastic tube market. Manufacturers are currently facing challenges related to plastic intolerance between end users and recycling of multi-layer plastic tubing, which can limit sales to some extent, so major players are We are adopting sustainable options to increase revenue and mitigate the environmental problems associated with the use of plastics, “said FMI analysts.

Increase sales with an easy-to-use design with transparent packaging of plastic tubes

Plastic tubing provides flexibility, shelf life, softness and a smooth look compared to aluminum wrapping tubing.

Therefore, end users prefer plastic tubing to metal wrapping tubing. This is because it can be squeezed to repel its properties and then return to its original shape. In addition, the demand for see-through packaging has increased significantly in the pharmaceutical and cosmetics industries.

Therefore, plastic tube manufacturers offer both transparent and opaque options with excellent luster and packaging finish. Also, these clear plastic tubing costs less to print, label, and decorate than aluminum tubing.

Therefore, as the demand for such see-through packages increases around the world, sales of plastic tubes are expected to increase in the near future.

Plastic tube market landscape

Albea SA, Berry Global, Inc., CCL Industries Inc., Linhardt GmbH & Co KG, Hutamaki Oyj, EPL Limited, Hoffmann Neopac AG and CTL-TH Packaging SL are major players in the global plastic tube market. Tier 1 players on the market account for 10-15% of the global plastic tube market.

Paper & Paperboard Anticipated to be the Most Preferred Material Type in the Global Consumer Electronics Packaging Market

Future Market Insights has recently conducted an extensive market study on the global consumer electronics packaging market and published the findings in a new report titled ‘Consumer Electronics Packaging Market: Global Industry Analysis (2012 – 2016) & Opportunity Assessment (2017 – 2027).’ The report provides in-depth market information and insights along with key metrics to study the performance of the global consumer electronics packaging market for an assessment period of 10 years from 2017 to 2027.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4793

According to the report forecasts, global sales of consumer electronics packaging is estimated to be valued at US$ 14,105.8 Mn by 2017 end and this is projected to reach US$ 35,393.3 Mn by 2027. Sales revenue is expected to expand at a CAGR of 9.6% during the forecast period (2017–2027).

The commoditisation of consumer electronics products, reducing product life cycles, and changing consumer buying patterns are some of the factors expected to boost revenue growth of the global consumer electronics packaging market. However, growing intolerance towards plastic, shifting regulatory environment, changing consumer preferences, and falling average disposable income levels are some factors expected to restrict global market revenue growth.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-4793

Global Consumer Electronics Packaging Market: Segmentation & Forecast

The global consumer electronics packaging market is segmented on the basis of Product Type into Corrugated Boxes, Paperboard Boxes, Thermoformed Trays, Bags & Pouches, Blister Packs & Clamshells, Protective Packaging, and Others; on the basis of Material into Plastic (PE, PP, PVC, PA, PET, PS, Others), Paper & Paperboard, and Others; on the basis of Application into Mobile Phones,

Computers (Laptops & Tablets, Desktops & Servers), TVs, DTH & Set-Top Boxes, Music Systems, Printers, Scanners & Photocopy Machines, Game Consoles & Toys, Camcorders & Cameras, Electronic Wearable, Digital Media Adapters (DMRs), and Others; and on the basis of Region into Western Europe, North America, Eastern Europe, Latin America, Asia Pacific Excluding Japan (APEJ), Middle East & Africa (MEA), and Japan.

Corrugated Boxes is the largest product type segment, estimated to hold just under 23% market share by 2027 end. This segment is expected to create an incremental $ opportunity of US$ 4,968.8 Mn during the forecast period.
The Mobile Phones application segment is anticipated to lead the global consumer electronics packaging market with a valuation of US$ 8,417.2 Mn by the end of the forecast period in 2027. This segment is expected to create an incremental $ opportunity of US$ 5,210.3 Mn over the forecast period.
The Paper & Paperboard material segment is estimated to hold a high value share of just under 62% by the end of 2027. This segment is expected to create an incremental $ opportunity of US$ 14,430.4 Mn during the forecast period.
APEJ is the dominant regional market for consumer electronics packaging with a high value share of 41.3% by the end of the forecast period in 2027. The APEJ consumer electronics packaging market is expected to gain 310 basis points in market share in 2027 over 2017.

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-4793

Global Consumer Electronics Packaging Market: Competition Tracking

The report profiles some of the top companies operating in the global consumer electronics packaging market such as DS Smith Plc, Mondi Group, International Paper Company, Sonoco Products Company, Sealed Air Corporation, Huhtamaki Oyj, Smurfit Kappa Group PLC, WestRock Company, UFP Technologies, Inc., Stora Enso Oyj, Pregis Corporation, Shenzhen Hoichow Packing Manufacturing Ltd., Dordan Manufacturing Company, Hangzhou Xunda Packaging Co., Dunapack Packaging Group, Universal Protective Packaging, Inc., Parksons Packaging Ltd., Neenah Paper Inc., Plastic Ingenuity Inc., and JJX Packaging LLC.

For more information on the global consumer electronics packaging market, Future Market Insights analysts can be contacted at press@futuremarketinsights.com

About Packaging Division at Future Market Insights

The Packaging division at FMI provides an in-depth historical analysis and granular projections of the global packaging market. Ranging from packaging materials to designs & formats, FMI has an exhaustive market research database, serving clients with unique offerings and strategic recommendations. With a repository of 750+ reports, the team analyzed the packaging industry comprehensively in 70+ countries. The team evaluates every node of the value chain and provides end-to-end research and consulting services; reach out to explore how we can help

Bubble Wrap Packaging Market to Amp Up with Growth of E-commerce and Subsequent Need to Protect Products during Transit: FMI

Future Market Insights delivers vital insights on the bubble wrap packaging market in its published report titled, “Bubble Wrap Packaging Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029”. In terms of revenue, the global bubble wrap packaging market is projected to expand at a CAGR of ~3% during the forecast period, owing to numerous factors upon which FMI offers thorough insights and forecasts in this report.

The global bubble wrap packaging market has been segmented on the basis of product, material, end-use industry, and region. The global market is expected to expand 1.4x in terms of market volume by the end of 2029.

Request a PDF Sample at https://www.futuremarketinsights.com/reports/sample/rep-gb-5612

Noteworthy Progression of Bubble Wrap Packaging in the e-Commerce Industry

Bubble wrapis a flexible and transparent plastic material used for the packaging of especially delicate items. Regularly spaced, protruding air-filled hemispheres (bubbles) provide cushioning for breakable items. Bubble wrap packaging is widely used in a number of end-use industries such as e-Commerce, manufacturing & warehousing, logistics, and transportation. The extensive application of bubble wrap packaging is identified in e-Commerce industry, and it is anticipated to increase at a CAGR of ~4% during the forecast period.

The retail industry has witnessed huge makeover in every sectors. Consumers are getting more inclined towards online purchasing due to rising consumers’ discretionary income and reluctance to spend more time on shopping. This leads to the steady progress in the e-Commerce industry.

Growing number of online resellers are motivating players such as Amazon and Target to come up with the best packaging formats to undercut rivals and offer cheaper, faster shipping with special packaging methods. Proetctive packaging and air pillows are favored means of protection, especially for online orders, thereby significant contributing to the growth of the bubble wrap packaging market.

According to study conducted by Pregis Corporation & Packaging Insights, it has been concluded that 73% of consumers are unlikely to repurchase from the company after receiving damaged items. Packaging is especially taken care of by all manufactures as they are focused on consumers’ needs and don’t want to lose them either. This would lead to surge in demand for bubble wrap packaging, as protective packaging plays a vital role to retain online customers and enhance the brand image of the company.

For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-5612

East Asia to Hold Prominent Share in the Bubble Wrap Packaging Market

Geographically, Asia holds nearly one-third of the world’s bubble wrap packaging market, and the trend is likely to continue in the years ahead, especially in the East Asia market. In addition, China and India are major markets, which are expected to witness high Y-o-Y growth in upcoming years.
Opportunity for the bubble wrap packaging market is likely to be less in the European region as compared to other global markets. Most of the governments in European regions are encouraging end users to prefer recyclable or degradable materials for packaging. This has motivated manufacturers including Vereinigte Papierwarenfabriken GmbH, Storopack Hans Reichenecker GmbH, Goldfoam Sp. o .o., and Sealed Air Corp. to develop greener bubble wrap packaging. Thorough research and innovation has led to develop iBubble wrap packaging, which is an eco-friendly product.
Countries in South Asia, especially India and Thailand markets are expected to grow at a significant rate in comparison to other countries in the region. In Europe, Benelux market is anticipated to witness a higher growth in the bubble wrap packaging market, while Italy is anticipated to face sluggish growth in bubble wrap packaging market in the region. Oceania, Latin America, and MEA regions are expected to cumulatively constitute one-sixth of the total share in the global bubble wrap packaging market. The Oceania bubble wrap packaging market is anticipated to remain steady in the upcoming years.
The North American bubble wrap packaging market is expected to witness sluggish growth. However, Latin America is projected to witness consistent growth in the bubble wrap packaging market in upcoming years, with the Mexico bubble wrap packaging market holding a prominent share due to its developing economy and high chance of market expansion in years ahead.

Recyclable Content in Bubble Wrap as an Additional Value

Leading manufacturers’ choice includes addition of 25-60% recycled content in the bubble wrap packaging to reduce its environmental impact. Recyclable bubble wrap packaging will help manufacturers to maintain their foothold in the evolving protective packaging industry. The rise in awareness of drawbacks of plastic consumption and its non-disposable property have motivated manufactures to opt for recyclable packaging methods, especially for fragile products.

About Packaging Division at Future Market Insights

Lipase Testing Reagents Market Will Escalate Rapidly in the Near Future

Lipase Testing Reagents Market Overview

Lipases are the enzymes, those are responsible for the hydrolysis of fatty acids and esters in the body. Lipase testing reagents used to diagnose pancreatic disorders. Major application of the Lipase Testing Reagents in the diagnosis of acute and chronic pancreatic disorders. Lipase Testing Reagents works on the enzymatic color test principle. In which the color produced after the assay method, measured against the fixed wavelength to determine the Lipase level in serum and plasma. Lipase Testing Reagents acts as important markers to study the pancreas related disorders and gall bladder cancer. Pancreatic lipase test kits based on the turbid metric & colorimetric methods, in which triglyceride used as substrate. The lipase testing reagents uses the color rate assay, in which 1, 2- diglyceride acts as a natural substrate. Lipase testing reagents are highly sensitive towards the natural substrate and pancreatic lipase. In the lipase testing reagents, colipase and deoxycholate used as activators.

Lipase Testing Reagents Market: Drivers and Restraints

Rising patient pool suffering from the acute and chronic pancreatic disorders may drive the lipase testing reagents market. People suffering from the disorders like indigestion, gastroesophageal reflux disease (GERD) may show the fueling growth for lipase testing reagents market. Disease conditions like persistent diarrhea, vitamin deficiency, malnutrition will show the additional demand of the lipase testing reagents market. In children cystic fibrosis (CF) or Shwachman-Diamond Syndrome (SDS) diagnosis may show the propelling growth for lipase testing reagents market. Alternative diagnosis methods like CT scan, Endoscopy for the pancreatic testing may show the slower growth for lipase testing reagents market. Awareness of the people about the cystic fibrosis and pancreatic cancer may show the stagnancy in the lipase testing reagents market.

Lipase Testing Reagents Market: Overview

Rising population of the pancreatic disorders is the main factor for the growth of lipase testing reagents market, however by indication type, pancreatic disorders expected to show the good revenue for the lipase testing reagents market. Cancer segment covers the various cancer related to the GIT, such as intestine cancer, stomach cancer etc., rising patient pool of gall bladder related complications and cancers expected to fuel the growth of the lipase testing reagents market. In the developing countries like India, South Africa & Brazil people suffering from the cystic fibrosis, in such scenarios cystic fibrosis diagnosis will show the good revenue for the lipase testing reagents market. By end user, hospitals segment expected to the high revenue share for the lipase testing reagents market, since the majority of population visiting to the hospitals is high, for the diagnosis of various disorders. Followed by the hospitals clinics wills show the good revenue for the lipase testing reagents market, since people normally visits the specialty clinics for the GIT related complications. Diagnostic center segment will show the lucrative growth in a developed countries for lipase testing reagents market, due to the more number of diagnostic and pathology labs in the developed countries, and people also visits for the routine body check up in the diagnostic center. In comparison to all the above end user, research centers may show the slower growth for pancreatic amylase reagent, since the very narrow level lipase testing reagents may requires on the occasional purpose.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-10569

Lipase testing reagents Market: Key Players

Examples of some of the market participants in lipase testing reagents market identified across the value chain include DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Sunson Industry Group Co.,Ltd, Randox Laboratories Ltd., Abbott, Beckman Coulter, Inc., Biocompare, Vitro Scient Co., Merck KGaA., Sisco Research Laboratories Pvt. Ltd. Biosystems S.A ,and others.

The research report on lipase testing reagents market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on lipase testing reagents market provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on lipase testing reagents market:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Report on lipase testing reagents market includes regional analysis:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Europe (Germany, Italy, France, U.K, Spain, , Russia)
East Asia (China, Japan, South Korea)
South Asia (India, ASEAN)
Oceania (Australia, New Zealand)
Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report on lipase testing reagents market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For any queries linked with the report, ask an analyst >> https://www.futuremarketinsights.com/ask-question/rep-gb-10569

Automated CPR Devices Market is slated to grow at approximately 13% CAGR throughout the forecast period

The demand for automated CPR devices has been increasing significantly with rising prevalence of sudden cardiac arrest across the globe, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global automated CPR devices market is slated to grow at approximately 13% CAGR throughout the forecast period from 2021 to 2031.

Major progress has been witnessed with 3D automatic CPR devices, especially when normal CPR device coupled with torso restraints providing vertical compression and high quality resuscitation.

Automated CPR devices experienced a surge in demand during the Covid-19 pandemic. COVID-19 infected heart patients were more susceptible to cardiac arrest in comparison with non infected patients. With rapid mutation of virus, the patients were facing higher risk of cardiac arrest.

The market is anticipated to grow significantly over the forthcoming decade, as majority of coronary and intensive care units are inclining towards automated CPR devices for its high effectiveness.

Key Takeaways from FMI’s Automated CPR Devices Market Study

Presence of modern healthcare infrastructure and high per capita income will bolster demand across the U.S.
The U.K is expected to offer growth opportunities as governments and private organizations are working towards spreading awareness regarding dangers of cardiovascular diseases.
Rising prevalence of obesity and high blood pressure which are precursor to cardiac arrest will increase automated CPR devices adoption across France.
China will offer lucrative opportunities owing to increasing alcohol and tobacco consumption and developing healthcare infrastructure.
India is expected to exhibit impressive market growth owing to increase in geriatric population and growing incidence of sudden cardiac arrest in the country.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-720

Competitive Landscape

Automated CPR market is highly consolidated owing to presence of regional and global market players. Key market players in automated CPR devices market are focusing towards employing inorganic market strategies to expand their global foothold.

Inorganic strategies include strategic merger and acquisition and forming an alliance with regional distributors to strengthen their supply chain channels.

They are also emphasizing towards faster product approvals, product development and patenting. New market entrants are focusing on new product launches to establish their market presence.

For instance, Michigan Instruments launched hand-free automatic CPR device which is light weight, portable and helps in smooth transition from manual CPR to automated compressions.

ZOLL Medical Corporation introduced a new automated CPR devices system “Autopulse” which assists EMS personnel in providing high quality chest compressions in cramped spaces and steep down stairwells.

Prominent players operating in the automated CPR devices market are SunLife Science Inc., ZOLL Medical Corporation, Michigan Instruments, Physio Control Inc., Brunswick Biomedical Technologies, Zhuhai Kindway Medical Science & Technology Co. Ltd, CPR Medical Devices Inc., and Medtronic Inc.

More Insights on the Global Automated CPR Devices Market

In its latest report, FMI offers an unbiased analysis of the global automated CPR devices market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of power source (pneumatically driven CPR devices, battery driven CPR devices, and mechanically actuated and battery driven CPR device), device type (piston devices, load distribution devices, and 3D compression devices) and end user for (Ems, hospitals, ambulances, coronary & intensive care units, cardiac catheterization labs, air med-evac units, and EMT rescue units) across North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-720

Stereotactic Planning Software Spending Analysis Market expected to reach US$ 128.2 Million by 2031

Stereotactic planning software is an interactive software tool used in stereotactic planning applications of recording chamber placement and electrode trajectories. It combines basic trajectory planning to obtain arc settings with advanced planning capabilities that improve O.R. workflows, localization of functional areas, and deep brain stimulation (DBS). According to the recent Future Market Insights (FMI) report, the global stereotactic planning software spending analysis is estimated to be US$ 252.6 Mn in 2021, with a market CAGR of 4.6% during the forecast period (2021-2031).

The high prevalence of neurological disorders and small cell lung cancer is expected to boost the demand in the stereotactic planning software market. For instance, Parkinson’s disease and other movement disorders are estimated to affect 2.75 million people in the United States. According to DALY’s, in the U.S., stroke accounts for 3.58 Mn people, Alzheimer’s disease for 2.55 Mn, and migraine for 2.4 Mn.

Furthermore, increasing investments in better treatment options involving precision and artificial intelligence in the software provide impetus to the market by increasing the overall adoption rate. Patients are inclined towards safer and better treatment facilities with minimal incision. Stereotactic planning software facilitates surgeons to plan stereotactic surgery efficiently.

However, the unprecedented impact of the ongoing covid-19 pandemic has created a significant impact on the stereotactic planning software market due to a shortage of inpatient footfalls in hospitals and other centers.

Preference now is being given to the treatment of COVID-19 patients, thus halting product launches for stereotactic planning. Also, this has led to the postponement of the enrolment of the new participants is such studies. Now, with the availability and commencement of the COVID-19 vaccination, the research activities expected to resume in the near future.

Key Takeaways from Stereotactic Planning Software Spending Analysis Market Study

Integrated stereotactic planning solutions are expected to grow 2x by 2031 as compared to 2021 owing to ease of use and higher adoption rates.
CT scans are projected to capture over 46% of the global market by 2031. This is attributed to inherent accuracy in identifying and localizing intracranial lesions.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6452

North America is the largest revenue-generating region for stereotactic planning software, with the U.S. accounting for over 79% of the regional market.
The U.K. holds the lead in Europe, accounting for over 37% of the region through the end of 2031.
East Asia is poised to grow at the highest CAGR of 5.3% during the forecast period with China accounting for over 62% of the market owing to the large subclinical patient pool of patients.

Who is Winning?

Some of the leading companies operating in the stereotactic planning software spending analysis market are focusing on collaborations and mergers and acquisitions for global expansion options with a focus on emerging economies. Thus, enhancing their market presence. For instance,

In March 2021, RaySearch Laboratories AB (publ) announced a sales agent agreement with Canon Medical Systems USA, Inc., enabling RaySearch America’s salesforce to promote Canon Medical’s Aquilion Large Bore CT and Celesteion PET/CT products.
In March 2021, Brainlab announced the acquisition of Mint Medical GmbH. The acquisition aims to improve the structured diagnosis, analysis, and treatment of cancer and other diseases to address the demands of modern medicine and personalized treatments.

The key market players covered by FMI include Brainlab, Inc., Renishaw Inc., Inomed Inc., RaySearch Americas, Inc., Mevis Informática Médica, FHC, Inc., Integra LifeSciences Corporation, Elekta Solutions AB, and SurgiFRONT Ltd.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-6452

Automated Suturing Devices Market is poised to expand at over 7.3% CAGR over 2031

Surging adoption of minimally invasive procedures due to the rising prevalence of cardiovascular disease and rising incidents leading to trauma and open surgeries is augmenting the growth of automated suturing devices market.

According to Future Market Insights, the global automated suturing devices is poised to expand at a CAGR of 7.3% to reach a valuation of approx. US$ 473 million through 2021 and beyond.

Increasing research & development for advanced automated suturing devices due to the rising adoption of minimally invasive procedure is anticipated to accelerate the demand across countries such as U.S., Japan, India, China and UK.

Use of automated suturing devices in minimal invasive surgeries, open surgical procedures and major trauma cases that require surgery is expected to drive the market across Asia Pacific excluding Japan (APEJ).

Rising preference for automated suturing devices over conventional ones during laparoscopic surgery is a major factor for market growth. Furthermore, the device is also preferred by procurement teams at hospitals as it’s labelled under “green products”, resulting in considerably less impact on the environment as compared to plastic single-use disposable suturing devices. Thereby, improving the market growth.

Key Takeaways from FMI’s Automated Suturing Devices Market Study

By product type, disposable automated suturing devices to emerge as lucrative segment through 2021
Increasing application in minimally invasive surgeries to stimulate suturing devices sales
The U.S. is expected to experience noteworthy expansion amid robust presence of regional suture devices manufacturers, experiencing 1.9x growth
India and China are expected to offer lucrative opportunities across South Asia & East Asia
Japan is expected to register a stellar growth on the back of rising adoption of minimally invasive procedures
Growing cases of gastrointestinal diseases to widen automated suturing devices adoption across Germany

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-579

Competitive Landscape

Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery, EndoEvolution, LLC, LSI Solutions, Inc. and SuturTek Inc. are some prominent players operating in the automated suturing devices market.

Product development and innovation of new devices coupled with strategic mergers and acquisition remains the core strategy for the leading players to maintain a strong foothold in the industry.

In December 2019, for instance, a global leading player, Advanced Medical Solutions Group PLC, manufacturer of tissue adhesives, sutures, hemostats, and internal fixation devices, announced the acquisition of Biomatlante, a developer of synthetic bone graft technologies.

In September 2019, another leading player, Apollo Endosurgery, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Polypropylene Suture-Anchor Assembly for the use with the Over Stitch Endoscopic Suturing Systems.

Furthermore, in June 2018, Apollo Endosurgery, Inc. received Special 510(k) clearance from the U.S. Food and Drug Administration for Over Stitch Sx Endoscopic Suturing System. The endoscopic suturing systems allowed physicians to place full-thickness sutures from a flexible endoscope in endoscopic surgery.

More Insights on the Global Automated Suturing Devices Market

In its latest report, FMI offers an unbiased analysis of the global automated suturing devices market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (disposable and reusable), application type (minimally invasive surgeries, open surgeries, and trauma) across seven major regions (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa)

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-579

Oxycodone Market will rise consistently at 4.8% CAGR over 2031

ESOMAR-certified consulting firm Future Market Insight (FMI) has published a report on the global oxycodone market for the forecast period of 2021 – 2031. According to the report, the market is expected to expand at a CAGR of 4.8% during the forecast period.

Oxycodone belongs to a group of opioid analgesics that is generally used in pain management. It is used for both long and short term. Rising prevalence of orthopaedic diseases such as osteoporosis, fibromyalgia, rheumatoid arthritis and other types of chronic pain is boosting the demand for oxycodone in the global market.

According to the International Osteoporosis Foundation, osteoporosis is one of the most serious health concerns among women and around 30% of people in U.S and Europe are affected by it each year. Increasing medical ailment and post-operative pain is another factor influencing the demand for oxycodone market globally.

The market growth is expected to accelerate due to increasing research and development activities undertaken to innovate abuse-deterrent formulations. Advance drug formulation such as extended-release medication for pain relief is an example of improve formulation.

The market however could face certain restrains in growth as oxycodone has side effects such as bladder pain, abdominal cramps, vomiting, diarrhoea, and breathing problem. Moreover, overdose of oxycodone can lead to de-addiction. The market can also be impacted due to certain severe adverse psychological problems such as depression.

COVID-19 pandemic has affected healthcare industry as there has been a sharp reduction in demand due to lesser visits to healthcare facilities such as clinics and hospitals. The widespread of virus has affected workforce in hospitals and other staffing issues as well.

Key Takeaways from FMI’s Oxycodone Market Study

Increasing penetration of pain management drugs, coupled with favourable reimbursement policies will drive sales in the U.S.
Within the Middle East and Africa, the demand in GCC countries will rise backed by investment towards expansion of the healthcare sector
The U.K., Italy, and France are likely to account for sizeable share in the Europe market for oxycodone

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7638

Long-acting oxycodone sales will rise steadily owing to surging application in pain management
Hospital pharmacies will continue exhibiting high demand for oxycodone, driven by higher footfall of patients

Who is Winning?

The key payers operating in the global oxycodone market are focusing on adopting numerous strategies such as mergers and acquisitions, research and development activities, and joint ventures. The key players operating in the global market are Janssen Pharmaceuticals (A Johnson and Johnson Subsidary), Inc., Purdue Pharma L., Hikma Pharmaceuticals USA, Inc., Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Sanofi-Aventis S.A., and others.

FDA in 2017 approved RoxyBond, a novel formulation of immediate-release oxycodone. This is the first approved immediate release opioid analgesic formulation with labelling that describes its abuse-deterrent properties.
In September 2019, Daiichi Sankyo Company in Japan, launched its generic formulated oxycodone hydrochloride hydrate extended release tablets for cancer pain treatment.

More Insight on the Global Oxycodone Market

In the latest study, Future Market Insights gives a detailed insight on the global oxycodone market, providing historical data for the period from 2016 to 2020 and forecast statistics for the period of 2021 – 2031. To understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (long-acting oxycodone and short-acting oxycodone), application segment (pain management and de-addiction), distribution channel (hospitals pharmacies and retail pharmacies), and region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-7638

Ocular Drug Delivery System Market is forecast to exhibit 6.8% CAGR between 2021 and 2031

According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably, enabling the market to surpass US$ 14,471.2 Mn in valuation by the end of 2021. The market is forecast to exhibit 6.8% CAGR between 2021 and 2031.

Ocular drug delivery systems are designed for dispensing drug, biologic, biopharmaceutical, and botanical therapeutics for treating macular degeneration, glaucoma, presbyopia, allergy, anti-viral, dry eye, anti-infective and anti-inflammatory indications.

To overcome the ocular drug delivery barriers and improve ocular bioavailability, various conventional and novel drug delivery systems have been developed such as ointments, emulsion, suspensions, aqueous gels, Nano micelles, liposomes, , and in situ thermosensitive gels for the earlier mention ocular diseases.

Glaucoma is the second-leading cause of blindness worldwide, accounting for up to 8% of total blindness. In India, glaucoma is the leading cause of irreversible blindness with at least 12 million people affected and nearly 1.2 million people blind from the disease. More than 90 percent of glaucoma cases remain undiagnosed in the community.

Thus the high incidence of ophthalmic diseases, resulting in the rise significant patient population, is driving the global ocular drug delivery systems market.

Ocular drug has to pass the water-fat-water membranous structure of cornea and this changing environment presents a significant barrier. That is why, for almost four decades, researchers have been involved in developing intraocular sustained-release drug delivery platforms.

Owing to the rigorous research studies, approvals for new ocular drug delivery techniques are currently recorded globally. This has helped the market to gain momentum over the last few years.

Key Takeaways from Ocular Drug Delivery System Market Study

Increasing focus on pharmaceutical innovation and research on drug delivery technologies is driving a transition towards particulate drug delivery systems, which will account for over 68% of the market in 2021.
Ophthalmic solution for ocular drug delivery system is expected to account for 60% the global market share by 2031.
Among distribution channels, hospital pharmacies accounted for 40% of the market share in 2031. Soaring influx of patients for treatment and availability of intensive care support have propelled the demand in the sehment.
North America holds the maximum share, owing to the presence of Tier1 players, high per-capita healthcare expenditure, and favorable reimbursement policies in the region.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6027

The U.S. holds a more than 44% share in the global ocular drug delivery systems market.
The U.K. and Germany are leading markets in Europe, accounting for more than 41% of the Europe market in 2021.
South Korea is the fastest growing market in East Asia, exhibiting 10.3% CAGR through 2031.

Increase in Funding for Research Activities Offers Growth Opportunities

Leading manufacturers in the ocular drug delivery system market are strengthening their market position through collaboration with various other organizations. Governments in developed and developing countries are actively taking initiatives to encourage research pharmaceutical products.

For instance, In April, 2017, Santen Pharmaceuticals announced a strategic investment in Regenerative Patch Technologies LLC, a U.S. based company engaged in development of ophthalmic therapies.

Pharmaceutical giants are expected to benefit from the globalization of labor forces, that is, employment of skilled local labor at cheaper rates to derive larger cost savings. Furthermore, this will create room for research and development (R&D) investments.

As per data from EFPIA and PhRMA, annual pharmaceutical (R&D) expenditures increased at 2.5% p.a. in Europe as compared to 3.3% p.a. in the U.S. over the latest measurable period 2016-2020. This will also create opportunities for the expansion of the market.

Who is Winning?

The global market is set to expand due to the rising prevalence of eye infections. Leading players within this space are expected to focus on research and development to offer an early and precise diagnosis of ailment, besides offering effective patient care.

Some of the leading players in the ocular drug delivery system market include but are not limited to Allergan Plc., Graybug Vision Inc., Ocular Therapeutix, Inc., Alimera Sciences, pSivida, Santen Pharmaceutical Co., Ltd, Taiwan Liposome Company Ltd., Envisia Therapeutics, Eyegate Pharma, Valeant Pharmaceuticals International, Inc, Vision Ophthalmology Group GmbH, Clearside Biomedical, URSAPHARM Arzneimittel GmbH.

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global ocular drug delivery systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the ocular drug delivery systems treatment on basis of the key indication in detail, cover every aspect of the market such as technology, dosage form, distribution channel across seven major regions.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-6027